RxSight, Inc. (RXST)

NASDAQ: RXST · IEX Real-Time Price · USD
55.83
+0.88 (1.60%)
At close: Feb 20, 2024, 4:00 PM
56.05
+0.22 (0.39%)
After-hours: Feb 20, 2024, 7:57 PM EST
1.60%
Market Cap 2.00B
Revenue (ttm) 76.59M
Net Income (ttm) -55.04M
Shares Out 35.86M
EPS (ttm) -1.72
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 756,920
Open 55.91
Previous Close 54.95
Day's Range 53.44 - 56.10
52-Week Range 13.00 - 56.85
Beta 1.20
Analysts Strong Buy
Price Target 39.43 (-29.37%)
Earnings Date Feb 28, 2024

About RXST

RxSight, Inc., an ophthalmic medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual cor... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date Jul 30, 2021
Employees 292
Stock Exchange NASDAQ
Ticker Symbol RXST
Full Company Profile

Financial Performance

In 2022, RxSight's revenue was $49.01 million, an increase of 116.90% compared to the previous year's $22.59 million. Losses were -$66.76 million, 37.1% more than in 2021.

Financial Statements

Analyst Forecast

According to 7 analysts, the average rating for RXST stock is "Strong Buy." The 12-month stock price forecast is $39.43, which is a decrease of -29.37% from the latest price.

Price Target
$39.43
(-29.37% downside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

RxSight, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024

ALISO VIEJO, Calif., Feb. 14, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) - RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following ...

6 days ago - GlobeNewsWire

RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance

ALISO VIEJO, Calif., Jan. 07, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery,...

6 weeks ago - GlobeNewsWire

RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference

ALISO VIEJO, Calif., Dec. 27, 2023 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery,...

7 weeks ago - GlobeNewsWire

RxSight, Inc. Educational and Product Announcements for AAO 2023

ALISO VIEJO, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- November 2, 2023 – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients followin...

3 months ago - GlobeNewsWire

RxSight, Inc. to Present at the Wells Fargo Healthcare Conference

ALISO VIEJO, Calif., Aug. 23, 2023 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery,...

6 months ago - GlobeNewsWire

RxSight, Inc. Reports Second Quarter 2023 Financial Results

ALISO VIEJO, Calif., Aug. 07, 2023 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery,...

7 months ago - GlobeNewsWire

RxSight, Inc. to Report Second Quarter Financial Results on August 7, 2023

ALISO VIEJO, Calif., July 25, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following ...

7 months ago - GlobeNewsWire

RxSight, Inc. Reports First Quarter 2023 Financial Results

ALISO VIEJO, Calif., May 09, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following c...

10 months ago - GlobeNewsWire

RxSight, Inc. to Present at the Bank of America Healthcare Conference

ALISO VIEJO, Calif., April 26, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following...

10 months ago - GlobeNewsWire

RxSight, Inc. to Report First Quarter Financial Results on May 9, 2023

ALISO VIEJO, Calif., April 25, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following...

10 months ago - GlobeNewsWire

Multiple Surgeon Presentations to Highlight RxSight® Light Adjustable Lens System at Upcoming American Society of Cataract and Refractive Surgery Annual Meeting

ALISO VIEJO, Calif., April 24, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following...

10 months ago - GlobeNewsWire

RxSight, Inc. to Present at the Needham Healthcare Conference

ALISO VIEJO, Calif., April 05, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following...

11 months ago - GlobeNewsWire

RxSight, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results

ALISO VIEJO, Calif., March 06, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following...

1 year ago - GlobeNewsWire

RxSight, Inc. to Present at the Oppenheimer Healthcare Conference

ALISO VIEJO, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high quality customized vision to patients following cataract surgery,...

1 year ago - GlobeNewsWire

RxSight, Inc. to Report Fourth Quarter and Fiscal Year 2022 Financial Results on March 6, 2023

ALISO VIEJO, Calif., Feb. 21, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high quality customized vision to patients following ...

1 year ago - GlobeNewsWire

RxSight, Inc. Announces Full Exercise of Underwriters' Option to Purchase Additional Shares and Closing of its Public Offering of Common Stock

ALISO VIEJO, Calif., Feb. 14, 2023 (GLOBE NEWSWIRE) -- RxSight, Inc. (“RxSight®”), an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today ...

1 year ago - GlobeNewsWire

RxSight, Inc. Announces Pricing of Public Offering of Common Stock

ALISO VIEJO, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc. (“RxSight”), an ophthalmic medical device company dedicated to improving the vision of patients following cataract...

1 year ago - GlobeNewsWire

RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Financial and Operational Results

ALISO VIEJO, Calif., Jan. 08, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, to...

1 year ago - GlobeNewsWire

RxSight, Inc. to Report Third Quarter 2022 Financial Results on November 7, 2022

ALISO VIEJO, Calif., Oct. 24, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, toda...

1 year ago - GlobeNewsWire

RxSight, Inc. Files Shelf Registration Statement and Announces $50 Million At-The-Market Equity Offering Program

ALISO VIEJO, Calif., Aug. 08, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, to...

1 year ago - GlobeNewsWire

RxSight, Inc. Reports Second Quarter 2022 Financial Results

ALISO VIEJO, Calif., Aug. 08, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, to...

1 year ago - GlobeNewsWire

RxSight, Inc. to Report Second Quarter 2022 Financial Results on August 8, 2022

ALISO VIEJO, Calif., July 25, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, to...

1 year ago - GlobeNewsWire

Surgeon Presentations to Highlight RxSight® Light Adjustable Lens System at Upcoming American Society of Cataract and Refractive Surgery Annual Meeting

ALISO VIEJO, Calif. , April 19, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery,...

2 years ago - GlobeNewsWire

RxSight, Inc. to Present at the Needham Virtual Healthcare Conference

ALISO VIEJO, Calif., March 28, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, ...

2 years ago - GlobeNewsWire

RxSight, Inc. Reports Fourth Quarter and Fiscal Year 2021 Financial Results

ALISO VIEJO, Calif., March 08, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, tod...

2 years ago - GlobeNewsWire